

A provider's guide to helping patients afford Trifluridine. Explore savings programs, discount cards, generics, and cost conversation strategies.
When you prescribe Trifluridine 1% ophthalmic solution for herpes simplex keratitis, you're prescribing a medication that requires frequent dosing (up to 9 drops per day), refrigerated storage, and strict adherence over 14 to 21 days. If your patient can't afford to fill the prescription, none of that matters.
Trifluridine's cost is a real barrier. The retail cash price for a single 7.5 mL bottle runs $300 to $400 — a significant out-of-pocket expense for patients without adequate prescription coverage. As a prescriber, you're in a unique position to help patients navigate the financial landscape before they leave your office.
This guide covers the savings options available for Trifluridine and practical strategies for building cost conversations into your workflow.
Here's the cost landscape for Trifluridine in 2026:
For a medication used to prevent corneal scarring and vision loss, cost-driven non-adherence is particularly concerning. A patient who uses drops less frequently than prescribed — or doesn't fill the prescription at all — risks treatment failure and potential permanent vision damage.
Unlike many brand-name medications, generic Trifluridine does not have a dedicated manufacturer savings card. The original brand, Viroptic, has been off-patent for years, and current generic manufacturers (Sandoz, Apotex) do not offer direct-to-patient discount programs.
However, Pfizer RxPathways may offer assistance for eligible patients who need help affording their medications. RxPathways connects patients with various Pfizer assistance programs and can be reached at 1-844-989-PATH (7284) or at pfizerrxpathways.com.
For patients with financial hardship, the following resources can help identify assistance options:
These programs typically have income eligibility requirements and may take time to process. For urgent prescriptions like Trifluridine (where treatment delay risks vision), consider bridging strategies while PAP applications are pending.
Prescription discount cards are the most immediate way to reduce out-of-pocket costs for patients paying cash or with high-deductible plans. The major options for Trifluridine include:
Clinical tip: Encourage patients to compare prices on multiple platforms before filling. Prices can vary significantly between pharmacies — even within the same chain — and between different coupon providers. The savings can be $50 to $150 per fill.
Important: Discount cards cannot be combined with insurance. Patients should compare their insurance copay to the discount card price and use whichever is lower.
Trifluridine itself is the generic — there's no cheaper generic option below it. However, when cost or availability is a significant barrier, therapeutic substitution is worth considering:
When making therapeutic substitution decisions, weigh the severity of the epithelial disease, patient compliance capacity, insurance formulary placement, and overall cost burden.
A few practical steps your office can take:
Many ophthalmologists and optometrists don't routinely discuss medication cost with patients. Here's how to make it seamless:
Trifluridine is a critical medication for preserving vision in patients with herpes simplex keratitis. But a prescription that doesn't get filled — because of cost, availability, or both — doesn't help anyone. By familiarizing yourself with the savings landscape, building cost awareness into your prescribing workflow, and connecting patients with resources proactively, you can improve adherence and outcomes.
For availability information and provider resources, visit Medfinder for Providers.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.